Bionomics Ltd ADR News

BNOXDelisted Stock  USD 4.88  0.07  1.41%   
Slightly above 55% of Bionomics' investor base is interested to short. The analysis of current outlook of investing in Bionomics Ltd ADR suggests that many traders are impartial regarding Bionomics' prospects. Bionomics' investing sentiment can be driven by a variety of factors including economic data, Bionomics' earnings reports, geopolitical events, and overall market trends.
  
over six months ago at news.google.com         
Bionomics stock retains Buy rating from H.C. Wainwright By Investing.com - Investing.com
Google News at Macroaxis
over six months ago at news.google.com         
Closing Bell Recap Bionomics Ltd. ADR Ends at 0.84, Reflecting a -14.97 Downturn DWinneX - The Dwinn...
Google News at Macroaxis
over six months ago at finance.yahoo.com         
Bionomics Limited Announces Private Placement of up to 70.0 Million
Yahoo News
over six months ago at investing.com         
Bionomics secures 70 million in private placement
Investing News at Macroaxis
over six months ago at news.google.com         
Ratios Reveal Breaking Down Bionomics Ltd. ADR s Financial Health DWinneX - The Dwinnex
Google News at Macroaxis
over six months ago at news.google.com         
Bears are Losing Control Over Bionomics Limited Unsponsored ADR , Heres Why Its a Buy Now - Yahoo Mo...
Google News at Macroaxis
over six months ago at news.google.com         
Bears are Losing Control Over Bionomics Limited Unsponsored ADR , Heres Why Its a Buy Now - Yahoo Si...
Google News at Macroaxis
over six months ago at investing.com         
Bionomics reports promising PTSD treatment trial results
Investing News at Macroaxis
over six months ago at benzinga.com         
Bionomics Reveals Detailed Data From PTSD Trial, Stock Soars
benzinga news
over six months ago at finance.yahoo.com         
Bionomics First Half 2024 Earnings AU1.62 loss per share
Yahoo News
over six months ago at simplywall.st         
Bionomics First Half 2024 Earnings AU1.62 loss per share
Simply Wall St News at Macroaxis
over a year ago at thelincolnianonline.com         
Short Interest in Bionomics Limited Decreases By 8.2
news
over a year ago at benzinga.com         
Bionomics to Present at the 2024 BIO CEO Investor Conference
benzinga news
over a year ago at news.google.com         
Jazz Pharmaceuticals PTSD Drug Misses Study Goals - Zacks Investment Research
Google News at Macroaxis
over a year ago at thelincolnianonline.com         
Bionomics Earns Buy Rating from HC Wainwright
news
Far too much social signal, news, headlines, and media speculation about Bionomics that are available to investors today. That information is available publicly through Bionomics media outlets and privately through word of mouth or via Bionomics internal channels. However, regardless of the origin, that massive amount of Bionomics data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Bionomics news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Bionomics relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Bionomics' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Bionomics alpha.

Bionomics Performance against Dow Jones

 Price Growth (%)  
       Timeline  
1
Bionomics to Present at the 2024 American College of Neuropsychopharmacology Annual Meeting
12/03/2024
2
Disposition of tradable shares by Papapetropoulos Spyros of Bionomics subject to Rule 16b-3
12/24/2024
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons.
You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.

Other Consideration for investing in Bionomics Stock

If you are still planning to invest in Bionomics ADR check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Bionomics' history and understand the potential risks before investing.
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Commodity Directory
Find actively traded commodities issued by global exchanges
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios